SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-23-104276
Filing Date
2023-09-27
Accepted
2023-09-27 16:05:14
Documents
1
Group Members
EUGENE SIKLOSPETER J. THOMSONSTRUCTURED ALPHA LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2326986d1_sc13da.htm SC 13D/A 89658
  Complete submission text file 0001104659-23-104276.txt   91447
Mailing Address 440 ARMAND-FRAPPIER BLVD. SUITE 300 LAVAL A8 H7V 4B4
Business Address 231 DUNDAS STREET EAST BELLEVILLE A6 K8N 1E2 450-781-0115
Liminal BioSciences Inc. (Subject) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91242 | Film No.: 231284786
SIC: 2834 Pharmaceutical Preparations

Mailing Address 138 SOUTH PARK ST. SAN FRANCISCO CA 94107
Business Address 138 SOUTH PARK ST. SAN FRANCISCO CA 94107 (415) 329-8400
Thomvest Asset Management Ltd. (Filed by) CIK: 0001795531 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13D/A